Exelixis Financial Statements (EXEL)
|
|
|
|
Report date
|
|
|
25.02.2020 |
11.02.2021 |
18.02.2022 |
07.02.2023 |
06.02.2024 |
|
29.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
967.8 |
987.5 |
1 435 |
1 611 |
1 830 |
|
2 020 |
|
Operating Income, bln rub |
|
|
369.5 |
110.1 |
286.7 |
201.5 |
170.9 |
|
523.7 |
|
EBITDA, bln rub |
? |
|
369.5 |
110.1 |
300.3 |
222.4 |
196.6 |
|
602.9 |
|
Net profit, bln rub |
? |
|
321.0 |
111.8 |
231.1 |
182.3 |
207.8 |
|
466.9 |
|
|
OCF, bln rub |
? |
|
527.0 |
209.0 |
400.8 |
362.6 |
333.3 |
|
470.3 |
|
CAPEX, bln rub |
? |
|
12.8 |
30.3 |
64.2 |
138.5 |
163.0 |
|
62.7 |
|
FCF, bln rub |
? |
|
514.1 |
178.6 |
336.6 |
224.2 |
170.4 |
|
457.1 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
565.2 |
841.2 |
1 095 |
1 352 |
1 587 |
|
1 464 |
|
Cost of production, bln rub |
|
|
33.1 |
36.3 |
52.9 |
57.9 |
72.5 |
|
78.0 |
|
R&D, bln rub |
|
|
337.0 |
547.9 |
693.7 |
891.8 |
1 044 |
|
906.1 |
|
Interest expenses, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
26.3 |
|
|
Assets, bln rub |
|
|
1 886 |
2 137 |
2 616 |
3 071 |
2 942 |
|
2 960 |
|
Net Assets, bln rub |
? |
|
1 686 |
1 879 |
2 211 |
2 488 |
2 264 |
|
2 275 |
|
Debt, bln rub |
|
|
50.7 |
49.1 |
51.3 |
190.2 |
189.9 |
|
194.4 |
|
Cash, bln rub |
|
|
852.2 |
1 207 |
1 467 |
1 308 |
995.3 |
|
1 189 |
|
Net debt, bln rub |
|
|
-801.5 |
-1 157 |
-1 416 |
-1 118 |
-805.4 |
|
-994.7 |
|
|
Ordinary share price, rub |
|
|
17.0 |
20.1 |
18.3 |
16.0 |
24.0 |
|
20.1 |
|
Number of ordinary shares, mln |
|
|
302.6 |
308.3 |
314.9 |
321.5 |
318.2 |
|
285.6 |
|
|
Market cap, bln rub |
|
|
5 147 |
6 187 |
5 756 |
5 157 |
7 632 |
|
5 747 |
|
EV, bln rub |
? |
|
4 345 |
5 030 |
4 340 |
4 039 |
6 827 |
|
4 752 |
|
Book value, bln rub |
|
|
1 622 |
1 815 |
2 147 |
2 425 |
2 200 |
|
2 212 |
|
|
EPS, rub |
? |
|
1.06 |
0.36 |
0.73 |
0.57 |
0.65 |
|
1.63 |
|
FCF/share, rub |
|
|
1.70 |
0.58 |
1.07 |
0.70 |
0.54 |
|
1.60 |
|
BV/share, rub |
|
|
5.36 |
5.89 |
6.82 |
7.54 |
6.92 |
|
7.74 |
|
|
EBITDA margin, % |
? |
|
38.2% |
11.1% |
20.9% |
13.8% |
10.7% |
|
29.8% |
|
Net margin, % |
? |
|
33.2% |
11.3% |
16.1% |
11.3% |
11.4% |
|
23.1% |
|
FCF yield, % |
? |
|
9.99% |
2.89% |
5.85% |
4.35% |
2.23% |
|
7.95% |
|
ROE, % |
? |
|
19.0% |
5.95% |
10.5% |
7.33% |
9.18% |
|
20.5% |
|
ROA, % |
? |
|
17.0% |
5.23% |
8.83% |
5.93% |
7.06% |
|
15.8% |
|
|
P/E |
? |
|
16.0 |
55.3 |
24.9 |
28.3 |
36.7 |
|
12.3 |
|
P/FCF |
|
|
10.0 |
34.6 |
17.1 |
23.0 |
44.8 |
|
12.6 |
|
P/S |
? |
|
5.32 |
6.27 |
4.01 |
3.20 |
4.17 |
|
2.84 |
|
P/BV |
? |
|
3.17 |
3.41 |
2.68 |
2.13 |
3.47 |
|
2.60 |
|
EV/EBITDA |
? |
|
11.8 |
45.7 |
14.5 |
18.2 |
34.7 |
|
7.88 |
|
Debt/EBITDA |
|
|
-2.17 |
-10.5 |
-4.71 |
-5.03 |
-4.10 |
|
-1.65 |
|
|
R&D/CAPEX, % |
|
|
2 626% |
1 805% |
1 080% |
644.1% |
640.7% |
|
1 446% |
|
|
CAPEX/Revenue, % |
|
|
1.33% |
3.07% |
4.48% |
8.59% |
8.90% |
|
3.10% |
|
| Exelixis shareholders |
